Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sagi Har‐Nof"'
Autor:
Vikrant Palande, Tali Siegal, Rajesh Detroja, Alessandro Gorohovski, Rainer Glass, Charlotte Flueh, Andrew A. Kanner, Yoseph Laviv, Sagi Har‐Nof, Adva Levy‐Barda, Marcela Viviana Karpuj, Marina Kurtz, Shira Perez, Dorith Raviv Shay, Milana Frenkel‐Morgenstern
Publikováno v:
Molecular Oncology, Vol 16, Iss 10, Pp 2098-2114 (2022)
Glioblastoma (GBM) is the most common type of glioma and is uniformly fatal. Currently, tumour heterogeneity and mutation acquisition are major impedances for tailoring personalized therapy. We collected blood and tumour tissue samples from 25 GBM pa
Externí odkaz:
https://doaj.org/article/7404d3c9bebe4cf098a443e9081400b3
Autor:
Hilla Ben Pazi, Shady Jahashan, Sagi Har Nof, Samuel Zibman, Ornit Yanai-Kohelet, Limor Prigan, Nathan Intrator, Natan M. Bornstein, Marc Ribo
Publikováno v:
Frontiers in Neurology, Vol 15 (2024)
Integrated brain-machine interface signifies a transformative advancement in neurological monitoring and intervention modalities for events such as stroke, the leading cause of disability. Historically, stroke management relied on clinical evaluation
Externí odkaz:
https://doaj.org/article/b1a91cece8274fe3969f9258a7bbbc2c
Autor:
Orit Uziel, Andrew A. Kanner, Einat Beery, Sapir Lev, Meir Lahav, Suzana Horn‐Fichman, Sagi Har Nof, Yuseph Laviv, S. Yust‐Katz, Alexandra Amiel, Ramez Abu Shkara, Mustafa Siddeeq, Adva Levy‐Barda, Pia Raanani, Yaron Sela, Zvi Cohen, Tali Siegal
Publikováno v:
Cancer Medicine, Vol 13, Iss 1, Pp n/a-n/a (2024)
Abstract Background In order to proliferate indefinitely, all tumors require a telomere maintenance mechanism. The expression of human telomerase reverse transcriptase (hTERT) enables telomere maintenance and provides cancer cells with limitless repl
Externí odkaz:
https://doaj.org/article/c679b1f38357497cbf3ee4ce1ee5e9f9
Autor:
Vikrant Palande, Tali Siegal, Rajesh Detroja, Alessandro Gorohovski, Rainer Glass, Charlotte Flueh, Andrew A. Kanner, Yoseph Laviv, Sagi Har‐Nof, Adva Levy‐Barda, Marcela Viviana Karpuj, Marina Kurtz, Shira Perez, Dorith Raviv Shay, Milana Frenkel‐Morgenstern
Publikováno v:
Molecular oncology. 16(10)
Glioblastoma (GBM) is the most common type of glioma and is uniformly fatal. Currently, tumour heterogeneity and mutation acquisition are major impedances for tailoring personalized therapy. We collected blood and tumour tissue samples from 25 GBM pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b97356c3e7fb6d3cc0239d7fa5322cf4
https://pubmed.ncbi.nlm.nih.gov/34875133
https://pubmed.ncbi.nlm.nih.gov/34875133
Autor:
Alexandra Benouaich-Amiel, Marina Kurtz, Shlomit Yust-Katz, Adva Levy-Barda, Charlotte Flueh, Shira Perez, Milana Frenkel-Morgenstern, Rajesh Detroja, Andrew A. Kanner, Alessandro Gorohovski, Sagi Har Nof, Rainer Glass, Dorith Raviv Shay, Tali Siegal, Yoseph Laviv, Vikrant Palande
Publikováno v:
Neuro Oncol
BACKGROUND GBM is characterized by intratumoral heterogeneity. Tumor heterogeneity, clonal diversity and mutation acquisition hamper the ability to tailor personalized therapy for GBM. Tumor sampling has limited ability to accurately capture the mole
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad3f6b9b4162ef7c1998d7d20a36d0bb
https://doi.org/10.1093/neuonc/noaa215.705
https://doi.org/10.1093/neuonc/noaa215.705